NDC 42292-017-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-017
- Requested NDC
- 42292-017-01
- Package NDCs from labels
- 42292-017-01, 42292-017-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2025-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Mylan Institutional Inc. | Mylan Institutional Inc. | 2025-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42292-017-01 | Spironolactone and Hydrochlorothiazide | 1 in 1 BLISTER PACK | TABLET | 1 | 9 | |
| 42292-017-20 | Spironolactone and Hydrochlorothiazide | 100 in 1 CARTON | TABLET | 100 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-017-01 | EA - Each | 42292-017 | 8cd108e4-b464-4100-9b08-87c109e4ea12 | 1 | 2017-08-11 |
| 42292-017-20 | EA - Each | 42292-017 | 0113bb4e-b99c-4b82-b696-2531c5d9ad2c | 1 | 2017-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| benazepril hydrochloride and hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Padagis US LLC | 3e2d3974-38b0-49d0-8020-f74107584724 | 2023-05-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8cc154c2-2ed2-4d7c-95a5-e2946393270c | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1b72ecfd-a08d-48c5-a853-d3bc9ff882f1 | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Amneal Pharmaceuticals of New York LLC | d5a1db33-3046-407c-a557-6b41642164a9 | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ARCTIC ICE | MENTHOL | NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD. | 07f5ec88-fbdf-6801-e063-6294a90ab866 | 2023-05-01 | Warnings | L7T10EIP3A |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 460f922c-1fda-44a5-889e-d7009883176b | 2023-05-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5605f105-f7ec-473f-8beb-9e8955e8e26e | 2023-04-28 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | 3ba1f9f9-0037-4522-8605-e27dc8552b5b | 2023-04-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Baby Nighttime Mucus Plus Cold Relief | CALCIUM SULFIDE,PHOSPHORUS,SULFUR,RUMEX CRISPUS ROOT,SODIUM CHLORIDE,ARABICA COFFEE BEAN,ANEMONE PULSATILLA,SILICON DIOXIDE, GOLDENSEAL,ONION,BRYONIA ALBA ROOT,EUPHRASIA STRICTA AND MATRICARIA CHAMOMILLA | Hyland's Inc. | 736b2487-e81d-d172-e053-2a91aa0ab0cf | 2023-04-17 | Warnings | ETJ7Z6XBU4 |
| SPIRONOLACTONE | SPIRONOLACTONE | A-S Medication Solutions | 4514fa40-613e-46f5-bee4-3edc7cc9863f | 2023-04-16 | Warnings, Adverse reactions | 27O7W4T232 |
| Radialgin | CITRUS LIMONUM, FUCUS VESICULOSUS, HYDRANGEA ARBORESCENS, SODIUM ALGINATE, NATRUM MURIATICUM, PHOSPHORUS, AGATE, RADIUM BROMATUM, X RAY | Nutritional Specialties, Inc. | f1414ae2-4068-4076-bf11-b57a34ba5df2 | 2023-04-12 | Warnings | ETJ7Z6XBU4 |
| SPIRONOLACTONE | SPIRONOLACTONE | A-S Medication Solutions | 200b2a6a-f263-463e-a2e1-f4f74058a924 | 2023-04-07 | Warnings, Adverse reactions | 27O7W4T232 |
| SPIRONOLACTONE | SPIRONOLACTONE | Asclemed USA, Inc. | 731894f2-bb1b-4ff6-b8c4-b8722e173199 | 2023-04-07 | Warnings, Adverse reactions | 27O7W4T232 |
| ATO Tell | MENTHOL, GARLIC OIL | sunkyung trading | f8b5525c-b4bf-d2ee-e053-6394a90a61c5 | 2023-04-06 | Warnings | L7T10EIP3A |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 69c41abb-75f4-429b-905a-1ce967924aee | 2023-04-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 3464be28-5bab-4642-9d9b-8b425822dd07 | 2023-04-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone | SPIRONOLACTONE | Proficient Rx LP | dffac5dc-a111-4095-a96c-54cc5c3866e5 | 2023-04-01 | Boxed warning, Warnings, Adverse reactions | 27O7W4T232 |
| SPIRONOLACTONE | SPIRONOLACTONE | Proficient Rx LP | 18f11eed-9ef6-43f6-8db0-720c27563871 | 2023-04-01 | Warnings, Adverse reactions | 27O7W4T232 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Exelan Pharmaceuticals, Inc. | c40b15ec-6083-4778-bca8-3e895e5694e1 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Silicea | SILICON DIOXIDE | Boiron | 86d34721-7dfc-bf91-e053-2991aa0a70ae | 2023-03-27 | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.